Nomura Holdings
AXSM icon

Nomura Holdings’s Axsome Therapeutics AXSM Stock Holding History

Nomura Holdings’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.76M Sell
19,427
-5,210
-21% -$1.13M 0.01% 813
2026
Q1 		$4.16M Buy
+24,637
New +$4.26M 0.01% 696
2025
Q1 		– Sell
-2,500
Closed -$285K – 1777
2024
Q4 		$212K Sell
2,500
-6,463
-72% -$594K ﹤0.01% 2039
2024
Q3 		$806K Sell
8,963
-114
-1% -$9.95K ﹤0.01% 1169
2024
Q2 		$731K Buy
+9,077
New +$672K ﹤0.01% 1228

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Nomura Holdings's AXSM Position: Q2 2026 in Review

Nomura Holdings reduced its Axsome Therapeutics (AXSM) stake by 21% in Q2 2026, selling an estimated $1.13M and leaving 19,427 shares worth $4.76M. The position accounts for 0.01% of the portfolio, ranked #813.

Nomura Holdings first reported a position in AXSM in Q2 2024 and has held it in 5 quarters since. 461 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • Nomura Holdings held 19,427 shares of Axsome Therapeutics worth $4.76M as of Q2 2026.
  • Nomura Holdings sold 5,210 Axsome Therapeutics shares in Q2 2026, an estimated $1.13M.
  • Axsome Therapeutics made up 0.01% of Nomura Holdings's portfolio in Q2 2026, its #813 holding.
  • Nomura Holdings first reported a position in Axsome Therapeutics in Q2 2024 and has held it in 5 quarters since.
  • 461 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Nomura Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.